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1. Human skin epithelium and human skin were found to absorb both free bilirubin
and serum-bound bilirubin from an aqueous buffered medium. The serum-bound
bilirubin thus absorbed was readily released when human skin epithelium or human skin
were transferred to media containing no bilirubin. 2. The Km values for serum-bound
bilirubin were 1.8 x10-3M and 2.2X10-3M respectively for human skin epithelium and
human skin; corresponding K. values for free bilirubin were 3.0 x 10-4M and 5 x 10-4M. The
Vmax. for bound and free bilirubin was of the same magnitude, the apparent Vmax. being
1.0 and 1.66,umol/g of tissue for human skin epithelium and human skin respectively.
3. Whenhuman skin that had acquired a yellow tinge byabsorbingbilirubinwasincubated
inabuffered medium andexposed to amercury-vapour light, the yellowcolour disappeared
and decomposition products of bilirubin accumulated in the medium. 4. Experiments with
[3H]bilirubin indicated that the pigment absorbed by skin was photo-oxidized to products
that were soluble in water and the quantity and number of such products increased with
the time of exposure of human skin to the light-source. Under similar conditions
[3H]bilirubin alone in buffered medium was also oxidized and gave products which by
paper chromatography appeared to be different from those released by human skin that
had absorbed bilirubin. 5. The results suggest that by virtue of its large surface area
human skin can act as a matrix for the degradative action of light on bilirubin.
Newborn babies suffering from jaundice have a
highly yellow-tinted skin, and phototherapy with
visible light not only bleaches the skin area
exposed to light but also lowers serum bilirubin
concentrations (Cremer et al., 1958 Bergsma et al.,
1970; Anon., 1970a,b, 1972; Tabbe et al., 1972;
Bajpai et al., 1973). Studies by Behrman & Hsia
(1969) and Schmid (1971, 1972) suggest indirectly that
skin can provide an alternative medium for the
catabolism of bilirubin. However, detailed studies of
the ability of skin to concentrate and degrade
bilirubin have not been conducted. Previous studies
from this laboratory have shown that strips of skin
from albino rats, mice and guinea pigs can take up
and release bilirubin (Kapoor et al., 1973a,b). The
present paper reports the role of human skin in the
uptake and photodecomposition of bilirubin. A brief
report of this work has appeared (Kapoor & Krishna
Murti, 1973).
Experimental
Materials
Chemicals. Chemicals used were as specified by
Kapoor et al. (1973b). The purity of bilirubin
(E. Merck, Darmstadt, W. Germany) was confirmed
by the procedure of McDonagh & Assisi (1972)
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and had an e value of 59000-61 0001itre mol1 cm-
at 450nm in chloroform.
Methods
Preparation of material. Human skin epithelial
strips were obtained from the dorsal surface of fore-
arm and thighs of human adults (male) undergoing
plastic surgery. Human skin strips were taken from the
abdominal skin before suturing of the operated area.
The samples were transferred immediately to
chilled sterile 150mM-KCl. The adherent tissue was
scraped off with a sharp blade and the piece was
cut into smaller segments and used with minimum
delay in uptake experiments.
Uptake of bilirubin. Human skin epithelium or
human skin (500mg) was incubated in 5ml of
Krebs-Ringer buffer, pH7.5 (122mM-NaCl, 5.0mM-
KCI, 1.2mM-MgSO4, 1.OmM-CaCl2, 16mM-
Na2HPO4), containing either serum-bound or free
bilirubin (0.427mM) at 37°C. At various times the
samples were washed free of medium, homogenized
and used for the determination of bilirubin.
Efflux of bilirubin. Human skin epithelium or
human skin from the uptake experiments was
washed free of medium, suspended in fresh Krebs-
Ringer buffer of the same composition as given
above and shaken at 37°C in a metabolic bath (60
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strokes/min, 2cm amplitude). After the desired period
the tissue was removed and the medium assayed for
bilirubin content.
Uptake and efflux studies were carried out in the
dark, and skin segments and aqueous solutions in
which bilirubin was estimated were protected from
strong light.
Photodecomposition of bilirubin. Human skin
(500mg) which had previously absorbed bilirubin
was washed free from medium and suspended in
5ml of Krebs-Ringer buffer containing 50,ug of
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streptomycin and 50units of penicillin G (Glaxo
Laboratories of India, Bombay, India). Beakers
containing the suspensions were exposed to an 80W
shaded mercury-vapour lamp (Phillips, Calcutta,
India) from a height of20cm. Sterile water (0.25ml/h)
was added to replace water lost by evaporation.
Themedium was centrifuged at 3000g at 4°C and used
for study of decomposition products. Control
experiments were run where the aqueous buffer
without human skin contained bilirubin equivalent
to the amount absorbed by 500mg of human skin.
Concn. of bilirubin in incubation medium (mg/l00ml)
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Fig. 1. Uptake ofbilirubin by human skin epithelium and human skin
(a) Human skin epithelium; (b) graphical calculation of Km for human skin epithelium; (c) human skin; (d) graphical
calculation of Km for human skin. Skin epithelium or skin (500mg) was incubated in the presence of 0.0854-0.854mM free
or bound bilirubin in Krebs-Ringer buffer, pH7.5, at 37°C for 2h. The vertical bars represent ±S.D. of the mean value of
three experiments with duplicates. O, Free bilirubin; 0, serum-bound bilirubin.
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Fig. 2. Efflux ofbilirubinfrom human skin epithelium andhuman skin
(a) Human skin epithelium and (b) human skin (500mg) were incubated in 5ml of Krebs-Ringer buffer, pH7.5, containing
0.427 mM-serum-bound bilirubin at 370C for 2h, washed free from medium and then reincubated in 5ml of fresh
Krebs-Ringer buffer, pH7.5. Vertical bars represent ±S.D. of the mean value of three experiments with duplicates.
*, Bilirubin released into medium in 2h; ®, protein released into medium in 2h. ®, Initial concentration of bilirubin in
skin epithelium or skin when added to fresh Krebs-Ringer buffer.
Preparation of skin homogenates. Homogenates
(5%, w/v) were prepared by grinding the segments
to a paste first with the aid of a pestle and mortar
and subsequently in a power-driven glass homo-
genizer fitted with a Teflon pestle (3000rev./min for
2-3 min).
Purification of [3H]bilirubin. [3H]Bilirubin pre-
pared by the Wilzbach procedure as described by
Grodsky et al. (1962) was supplied by the Isotope
Division of Bhabha Atomic Research Centre,
Bombay, India. After two crystallizations from
chloroform and methanol, the material was diluted
with carrier bilirubin (0.25mg/ml of chloroform)
and crystallized five times from chloroform and
methanol until the final product showed a con-
stant specific radioactivity (Ostrow et al., 1961).
Purified [3H]bilirubin was dissolved in 0.1 M-Na2CO3,
equilibrated with aqueous bovine serum albumin and
extracted with acetone to constant specific radioacti-
vity. Before dilution the e value in chloroform at
450nm was 56000 litre molh-cm-1. The specific
radioactivity was 7fuCi/4umol, measured against an
internal reference standard, n-[1,2-3H]hexadecane
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(The Radiochemical Centre, Amersham, Bucks.,
U.K.).
Determination of radioactivity. At various times
0.2ml portions of medium were removed and
spotted on 2cm x 2cm squares cut out of Whatman
3MM paper. After drying the squares were placed in
15-20ml of scintillation fluid [0.4% 2,5-diphenyl-
oxazole and 0.04% 1,4-bis-(4-methyl-5-phenyloxazol-
2-yl)benzene in distilled toluene] and counted for
radioactivity in a Packard Tri-Carb liquid-scintil-
lationspectrophotometer(efficiency4O 43%).Counts
registered by 0.1 and 0.2ml portions of [3H]bilirubin
in toluene were 10793 and 20865d.p.m. respectively.
The results have been corrected for this quenching
by Whatman 3MM paper.
Chromatographic separation ofphotodecomposition
products. Media from light-exposure experiments
were freeze-dried. From the residue, water-soluble
decomposition products were extracted by the pro-
cedure of Ostrow & Branham (1970). The material
thus extracted was applied to Whatman no. 1 sheets
and developed in the descending direction in the
solvent system of Gray et al. (1972). The paper was
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then dried. The distance between origin and sol-
vent front was divided into 2cm sections. Squares
(2cm x 2cm) were cut out of the strip, dropped into
scintillation fluid and counted for radioactivity.
Chemical determinations. Bilirubin in skin homo-
genates was measured by the procedure of Van Roy
et al. (1971) with a recovery of 94%. Bilirubin in
aqueous solutions was determined by the procedure
of Malloy & Evelyn (1937). Protein in serum or
medium was determined by the colorimetric method
of Lowry et al. (1951) with crystalline dry bovine
serum albumin (Sigma Chemical Co., St. Louis,
Mo., U.S.A.) as a standard.
Absorption spectra. Absorption was measured in
a Beckman DU model spectrophotometer in 1cm
light-path glass cuvettes.
Results
Uptake and efflux ofbilirubin by human skin segments
The uptake of free bilirubin or serum-bound
bilirubin by human skin epithelium and human skin
was affected by the concentration of bilirubin as
shown in Fig. 1. Both free bilirubin and serum-bound
bilirubin were readily absorbed, the former 3.5-fold
more than the latter. Double-reciprocal plots of the
data were linear. The apparent Km values for serum-
bound bilirubin were 1.8x 10-3M and 2.2x 10-3M
respectively for human skin epithelium and human
skin. Corresponding Km values for free bilirubin were
3.Ox10-4M and 5.OX 10-4M, whereas Vmax. values
were 1.0 and 1.66pmol/g of tissue for human skin
epithelium and human skin.
The serum-bound bilirubin absorbed by human
skin epithelium or human skin was released into the
medium when the skin segments which had
absorbed the pigment were incubated in Krebs-
Ringer buffer. The mean rates of efflux were 0.9nmol
/h per g for human skin epithelium and 1.5nmol/h
per g for human skin (Fig. 2). The efflux was relatively
fast in the first 30min. The relatively large amount of
free bilirubin absorbed by skin was, however, not
released into the medium.
Photodecomposition of bilirubin
[3H]Bilirubin dissolved in buffer or absorbed by
skin segments, suspended in buffer, was exposed to
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Fig. 3. Photodecomposition of bilirubin in Krebs-Ringer buffer or of free bilirubin bound to skin and suspended in
Krebs-Ringer buffer
Human skin (500mg) was first allowed to equilibrate with 0.427mM-bilirubin (equivalent to 0.43,Ci/,mol of [3H]bilirubin).
The samples were then exposed to the light-source as described in the text. Another set of beakers holding the same volume
of Krebs-Ringer buffer and containing 0.427mM-bilirubin with the same amount of [3H]bilirubin as used for skin were
also exposed to the light-source. The photodecomposition products obtained at 4h (a) and at 8h (b) were subjected to
descending paperchromatography in the system ethanol-aq. NH3 (sp.gr. 0.88)-water (16:1:3, by vol.). The paper chromato-
grams were scanned for radioactivity; the ordinate shows d.p.m. per unit length and the abscissa distance (cm) moved from
origin ofpaper chromatogram. *, [3H]Bilirubin absorbed in skin; A, [3H]bilirubin in Krebs-Ringer buffer. (a)4h-irradiated
samples; d.p.m. applied were 22050 (@) and 27550 (A). (b) 8h irradiated samples; d.p.m. applied were 38200(0) and
55945 (A)
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Fig. 4. Photodecomposition ofbilirubin absorbedfrom serum-bound bilirubin by skin
Human skin (500mg) was incubated at 37'C for 2h in 5ml of Krebs-Ringer buffer containing 0.427mM-serum-bound bili-
rubin. It was washed free from medium, suspended in 5rml of fresh Krebs-Ringer buffer and incubated either in the dark
or under exposure to the source of light. (a) Change in bilirubin content of skin incubated in the dark (@) and skin
exposed to source of light (A). (b) Visible absorption spectrum of medium after exposure to source of light.
the light-source and the products accumulating in
the medium were resolved by paper chromatography.
Fig. 3, shows that although [3H]bilirubin under-
goes photodecomposition even in aqueous solution
the extent of photodecomposition is much greater
when the pigment is absorbed by skin and exposed
to the source of light. The products of decomposition
also appear not to be the same as those obtained
when bilirubin is retained by the skin.
The above experiments were repeated with human
skin which had previously absorbed unlabelled free
bilirubin or unlabelled serum-bound bilirubin.
About 70-80% of the bilirubin was released into the
medium intact when human skin segments which had
absorbed serum-bound bilirubin were incubated in
the dark for 2h (Fig. 4a). When such human skin
segments were suspended in buffer and irradiated,
not only were they bleached but products showing an
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absorption maximum in the range of 390-400nm
were recovered in the medium. The absorption
maximum of bilirubin is 460nm (Fig. 4b).
Free bilirubin absorbed by human skin segments
showed a different response. There was no release of
bilirubin into the medium when segments which had
absorbed free bilirubin were incubated in the dark.
However, when such segrnents suspended in buffer
were irradiated, there was not only a gradual
bleaching of the segments but also release of photo-
decomposition products into the medium (see Fig. 5).
Discussion
The present study provides evidence to show that
human skin is involved in the homeostasis of bili-
rubin. Efflux studies indicate that serum-bound
bilirubin can exchange with serum proteins in the
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Fig. 5. Photodecomposition offree bilirubin absorbed by human skin
Humanskin(SOOmg)wasincubatedat37°Cfor2hin5mlofKrebs-RingerbuffercontainingO.427mM-bilirubin.Itwas washed
free from medium, suspended in 5ml of fresh Krebs-Ringer buffer and incubated either in the dark or under exposure
to the source of light. (a) Bilirubin content of skin incubated in the dark (@) and skin incubated under exposure to source of
light (A). (b) Visible absorption spectra of bilirubin (curve C) and of decomposition products in medium.
intravascular compartment of the skin (Kapoor
et al., 1973b). When sufficient bilirubin-binding sites
are available in serum proteins, bilirubin in circulation
could be transported into liver for its normal
disposal by conjugation with glucuronic acid. This
mechanism of disposal would probably be over-
strained in hyperbilirubinaemia, when free bilirubin
in circulation would be far in excess of the quantity
that normally saturates the available binding sites on
serum albumin.
The results presented show that human skin has
a greater affinity in vitro for free bilirubin than for
serum-bound bilirubin. The differences in the relative
rates of uptake and efflux of free or serum-bound
bilirubin presumably arise from the differential
rates at which the pigment can be absorbed by
different components of the skin. Lipid components
of skin and collagen can absorb bilirubin (Kapoor,
1973, 1974) and collagen appears to hold a relatively
high concentration of bilirubin as compared with
serum. The pigment bound to collagen is not readily
released but is nonetheless sensitive to light. It seems
likely, therefore, that the excess offree bilirubin in the
serum in neonatal jaundice can be absorbed by skin
inan irreversiblemanner. In contrast the serum-bound
bilirubin apparently exchanges with the serum
proteins in the intravascular space of skin. Although
bilirubin even in aqueous solution is degraded by
light, the absorption by skin facilitates the decom-
position of water-soluble products. The chemical
nature of these products will have to be established
before a plausible pathway of photodecomposition
can be postulated.
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